Insider Trading Summary for Athira Pharma, Inc. (ATHA): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
08-Jan-24 4:45 PM View:	04-Jan-24 Grant 0	Moebius Hans Chief Medical Officer		Athira Pharma, Inc. - ATHA	12% 81.48K to 91.48K	0	0	--	--	Show Txns Hide Txns

25-Jun-24 7:21 PM View:	24-Jun-24 Purchase $66.18K	Romano Kelly A Director		Athira Pharma, Inc. - ATHA	111% 38.31K to 80.72K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:48 PM View:	05-Sep-24 Sale ($1.43K)	Worthington Mark General Counsel		Athira Pharma, Inc. - ATHA	93% 26.86K to 51.93K	0	0	--	--	Show Txns Hide Txns

29-Dec-23 5:24 PM View:	29-Dec-23 Purchase $390.21K	Perceptive Advisors LLC Director 10% Owner		Athira Pharma, Inc. - ATHA	13% 4.8M to 5.4M	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:49 PM View:	05-Sep-24 Sale ($1.43K)	Church Kevin Chief Scientific Officer		Athira Pharma, Inc. - ATHA	15% 80.26K to 92.68K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:51 PM View:	05-Sep-24 Sale ($0.72K)	Gengos Andrew CFO AND CHIEF BUSINESS OFFICER		Athira Pharma, Inc. - ATHA	16% 83.8K to 97.53K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:50 PM View:	05-Sep-24 Sale ($1.43K)	Lenington Rachel COO AND CDO		Athira Pharma, Inc. - ATHA	259% 5.81K to 20.87K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:47 PM View:	05-Sep-24 Sale ($2.85K)	Litton Mark James President and CEO Director		Athira Pharma, Inc. - ATHA	20% 148.91K to 179.05K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--